Related Experiment Videos
Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions
T F Lüscher1, F C Tanner, G Noll
1Cardiology, Cardiovascular Research, University Hospital, Bern, Switzerland.
Insights
Endothelial dysfunction in coronary arteries, common in hypercholesterolemia, impairs relaxation and promotes adhesion. Statins and ACE inhibitors can improve endothelial function.
Area of Science:
- Cardiovascular Biology
- Endothelial Function
- Vascular Regulation
Background:
- Coronary arteries are regulated by various factors including neuronal, hormonal, and paracrine mediators.
- The endothelium plays a crucial role, releasing substances that modulate vascular tone, platelet function, coagulation, and monocyte adhesion.
- Key endothelial relaxing factors include nitric oxide (NO), prostacyclin, and a hyperpolarizing factor, while endothelin-1, thromboxane A2, and prostaglandin H2 are contracting factors.
Purpose of the Study:
- To review the mechanisms regulating coronary artery tone and structure.
- To highlight the significance of endothelium-dependent mechanisms in vascular health.
- To discuss the impact of hypercholesterolemia on endothelial function and the therapeutic effects of statins and ACE inhibitors.
Main Methods:
- Literature review of studies on endothelial function and regulation of coronary arteries.
- Analysis of the roles of specific mediators like nitric oxide, prostacyclin, endothelin-1, thromboxane A2, and prostaglandin H2.
- Examination of the effects of hypercholesterolemia and its pharmacological treatment on endothelial function.
Main Results:
- Endothelium-dependent relaxation is impaired in hypercholesterolemia, with enhanced contraction and monocyte/platelet adhesion.
- Nitric oxide and prostacyclin mediate relaxation and inhibit smooth muscle proliferation and platelet function.
- Endothelin-1, thromboxane A2, and prostaglandin H2 are key contracting factors, with thromboxane A2 and prostaglandin H2 activating platelets.
Conclusions:
- Hypercholesterolemia significantly disrupts endothelial function, leading to impaired vasodilation and increased pro-atherogenic processes.
- Pharmacological interventions such as statins and angiotensin-converting enzyme (ACE) inhibitors can effectively improve or normalize endothelial dysfunction.
- Understanding these mechanisms is vital for managing cardiovascular diseases associated with endothelial impairment.
Abstract:
Coronary arteries are regulated by neuronal mechanisms, hormones and paracrine mediators. The importance of endothelium-dependent mechanisms has recently been recognized. The endothelium responds to mechanical and chemical signals from the blood by releasing mediators that modulate vascular tone and structure, platelet function, coagulation and monocyte adhesion. Important relaxing factors are nitric oxide, prostacyclin and a putative hyperpolarizing factor. Nitric oxide also inhibits smooth muscle proliferation and, together with prostacyclin, platelet function. Bradykinin-induced nitric oxide production is reduced by angiotensin-converting enzyme. Endothelin-1, thromboxane A2 and prostaglandin H2 are contracting factors. Thromboxane A2 and prostaglandin H2 activate platelets, while endothelin has no direct platelet effects, but causes smooth muscle proliferation. In hypercholestermia, endothelium-dependent relaxation is impaired and contraction as well as adhesion of monocytes and platelets enhanced. Pharmacological correction of hyperlipidemia by statins also improves or normalizes endothelial dysfunction in patients. Angiotensin-converting enzyme inhibitors have similar effects.